Simplex Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Simplex Trading’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,800	Closed	-$115K	–	10784
2022 Q3	$115K	Buy	+8,800	New	+$133K	﹤0.01%	5332
2022 Q1	–	Sell	-300	Closed	-$5K	–	11653
2021 Q4	$5K	Buy	300 +100	+50%	+$1.92K	﹤0.01%	9597
2021 Q3	$4K	Hold	200	–	–	﹤0.01%	9378
2021 Q2	$3K	Buy	200 +52	+35%	+$1.22K	﹤0.01%	9661
2021 Q1	$430K	Buy	+148	New	+$4.14K	﹤0.01%	3589

Simplex Trading's NGM Position: Q2 2024 in Review

Simplex Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 28 shares.

Simplex Trading first reported a position in NGM in Q2 2020 and held it in 8 quarters. The position peaked at $243K in Q1 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Simplex Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 28 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024.
Simplex Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Simplex Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $243K in Q1 2021.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.